Breast Cancer with Low Recurrence Score on Oncotype DX © : Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation.
Yonaton ZarbivYael Berner WygodaAlbert GrinshpunTamar HamburgerTamar SellaShani BreuerOfra MaimonYakir RottenbergTamar PeretzLuna KadouriPublished in: Oncology and therapy (2022)
BRCA1/2 mutation and ILC are highly represented in this cohort. Although our cohort is small, these data may suggest that a RS ≤ 20 in these subgroups may not reflect a low risk of recurrence.